(Q21135459)

English

Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression

scientific article

Glycyrrhizin Exerts Antioxidative Effects in H5N1 Influenza A Virus-Infected Cells and Inhibits Virus Replication and Pro-Inflammatory Gene Expression

In more languages

Statements

scholarly article

0 references

Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression (English)

0 references

0 references

0 references

0 references

influenza A virus

object named as

influenza A virus

1 reference

based on heuristic

inferred from title

Hans Wilhelm Doerr

6

object named as

Hans Wilhelm Doerr

author given names

Hans Wilhelm

author last names

Doerr

1 reference

16 August 2022

Martin Michaelis

object named as

Martin Michaelis

1

author given names

Martin

author last names

Michaelis

1 reference

16 August 2022

Jindrich Cinatl

7

object named as

Jindrich Cinatl

author given names

Jindrich Jr

author last names

Cinatl

1 reference

16 August 2022

2

author given names

Janina

author last names

Geiler

object named as

Janina Geiler

1 reference

16 August 2022

3

author given names

Patrizia

author last names

Naczk

object named as

Patrizia Naczk

1 reference

16 August 2022

Patchima Sithisarn

4

author given names

Patchima

author last names

Sithisarn

object named as

Patchima Sithisarn

1 reference

16 August 2022

5

author given names

Anke

author last names

Leutz

object named as

Anke Leutz

1 reference

16 August 2022

language of work or name

0 references

publication date

2011

0 references

0 references

6

0 references

5

0 references

e19705

0 references

copyright license

Creative Commons Attribution 4.0 International

17 May 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

The broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelope

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

19 March 2017

Antiviral drugs for the control of pandemic influenza virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

19 March 2017

Vaccines for pandemic influenza. The history of our current vaccines, their limitations and the requirements to deal with a pandemic threat

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

19 March 2017

Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

19 March 2017

Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

19 March 2017

Avian influenza A (H5N1) infection in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

19 March 2017

Inhibition of influenza infection by glutathione

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

19 March 2017

Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

19 March 2017

Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

19 March 2017

N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Confronting the next influenza pandemic with anti-inflammatory and immunomodulatory agents: why they are needed and how they might work.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Nuclear factor 90 negatively regulates influenza virus replication by interacting with viral nucleoprotein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Glycyrrhizin inhibits influenza A virus uptake into the cell

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Of chickens and men: avian influenza in humans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Global transmission of oseltamivir-resistant influenza

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Use of oseltamivir in 12 European countries between 2002 and 2007--lack of association with the appearance of oseltamivir-resistant influenza A(H1N1) viruses.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Epidemiologic study of influenza infection in Okinawa, Japan, from 2001 to 2007: changing patterns of seasonality and prevalence of amantadine-resistant influenza A virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Human infection with highly pathogenic avian influenza virus (H5N1) in northern Vietnam, 2004-2005.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

H5N1 transmission and disease: observations from the frontlines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Influenza viruses and the NF-kappaB signaling pathway - towards a novel concept of antiviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Reduced sensitivity of influenza A (H5N1) to oseltamivir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Antiviral effects of Glycyrrhiza species

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

The threat of avian influenza A (H5N1). Part IV: Development of vaccines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

The threat of avian influenza A (H5N1). Part I: Epidemiologic concerns and virulence determinants.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

The threat of avian influenza A (H5N1). Part III: Antiviral therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

The threat of avian influenza a (H5N1): part II: Clues to pathogenicity and pathology.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Reactive oxygen species-induced activation of the MAP kinase signaling pathways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Oxidative stress and redox regulation of lung inflammation in COPD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Role of MAP kinase-dependent apoptotic pathway in innate immune responses and viral infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Distribution of amantadine-resistant H5N1 avian influenza variants in Asia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Cutting edge: apoptosis-regulating signal kinase 1 is required for reactive oxygen species-mediated activation of IFN regulatory factor 3 by lipopolysaccharide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Role of apoptosis and cytokines in influenza virus morbidity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Development of antiviral therapy for severe acute respiratory syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Inflammatory responses in influenza A virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Pharmacokinetics of intravenous glycyrrhizin after single and multiple doses in patients with chronic hepatitis C infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

12 September 2017

Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

27 September 2017

Induction of proinflammatory cytokines in primary human macrophages by influenza A virus (H5N1) is selectively regulated by IFN regulatory factor 3 and p38 MAPK.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

27 September 2017

Caspase 3 activation is essential for efficient influenza virus propagation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

27 September 2017

p38 mitogen-activated protein kinase and c-jun-NH2-terminal kinase regulate RANTES production by influenza virus-infected human bronchial epithelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

27 September 2017

Cell line A549 as a model of the type II pneumocyte. Phospholipid biosynthesis from native and organometallic precursors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

30 May 2018

High prevalence of amantadine-resistance influenza a (H3N2) in six prefectures, Japan, in the 2005-2006 season.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019705

21 January 2018

Increased incidence of adamantane-resistant influenza A(H1N1) and A(H3N2) viruses during the 2006-2007 influenza season in Japan

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019705

21 January 2018

Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019705

21 January 2018

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019705

21 January 2018

Infection of human retinal pigment epithelial cells with influenza A viruses.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019705

21 January 2018

Analysis of gene expression in human bronchial epithelial cells upon influenza virus infection and regulation by p38 mitogen-activated protein kinase and c-Jun-N-terminal kinase

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019705

21 January 2018

Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019705

21 January 2018

Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-induced pro-inflammatory cytokine and chemokine expression in human macrophages

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019705

21 January 2018

A novel immunomodulatory mechanism of ribavirin in suppressing natural killer cell function.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019705

21 January 2018

Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0019705

21 January 2018

The pandemic influenza vaccine challenge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

29 November 2018

[The anti-respiratory syncytial virus effect of active compound of Glycyrrhiza GD4 in vitro].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3096629

29 November 2018

Identifiers

10.1371/JOURNAL.PONE.0019705

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2011PLoSO...619705M

0 references

release_6ljvfdxmafcrpl2xcxlcktofjq

1 reference

https://api.fatcat.wiki/v0/release/6ljvfdxmafcrpl2xcxlcktofjq

24 November 2022

based on heuristic

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q21135459&oldid=1956122167"